This list is based on the watchlists of people on Stock Events who follow 94E.STU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
The current price of 94E.STU is €4.74 EUR — it has increased by +0.42% in the past 24 hours. Watch Zura Bio stock price performance more closely on the chart.
What is Zura Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Zura Bio stocks are traded under the ticker 94E.STU.
Is Zura Bio stock price growing?▼
94E.STU stock has fallen by -8.85% compared to the previous week, the month change is a -10.57% fall, over the last year Zura Bio has showed a +360.19% increase.
When is the next Zura Bio earnings date?▼
Zura Bio is going to release the next earnings report on May 07, 2026.
What were Zura Bio earnings last quarter?▼
94E.STU earnings for the last quarter are -0.42 EUR per share, whereas the estimation was -0.17 EUR resulting in a -149.68% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Zura Bio have?▼
As of April 13, 2026, the company has 40 employees.